Intuitive Surgical, Inc.

LSE:0R29 Stock Report

Market Cap: US$195.1b

Intuitive Surgical Future Growth

Future criteria checks 2/6

Intuitive Surgical is forecast to grow earnings and revenue by 11.5% and 13.4% per annum respectively. EPS is expected to grow by 11.2% per annum. Return on equity is forecast to be 14.3% in 3 years.

Key information

11.5%

Earnings growth rate

11.2%

EPS growth rate

Medical Equipment earnings growth22.5%
Revenue growth rate13.4%
Future return on equity14.3%
Analyst coverage

Good

Last updated15 Nov 2024

Recent future growth updates

Recent updates

Earnings and Revenue Growth Forecasts

LSE:0R29 - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202610,9802,8423,7274,33525
12/31/20259,5152,5242,7353,63729
12/31/20248,1412,1652,0663,28529
9/30/20247,8672,2435861,821N/A
6/30/20247,5732,0944201,663N/A
3/31/20247,3191,9885961,708N/A
12/31/20237,1241,7987501,814N/A
9/30/20236,8511,5171,2562,023N/A
6/30/20236,6651,4251,1781,858N/A
3/31/20236,4311,3121,0061,639N/A
12/31/20226,2221,3229581,491N/A
9/30/20226,1181,3781,0911,621N/A
6/30/20225,9641,4351,3101,739N/A
3/31/20225,9061,6441,4601,835N/A
12/31/20215,7101,7051,7502,089N/A
9/30/20215,4891,6891,8852,149N/A
6/30/20215,1631,6231,6621,922N/A
3/31/20214,5511,1731,3151,610N/A
12/31/20204,3581,0611,1431,485N/A
9/30/20204,3071,0539881,410N/A
6/30/20204,3581,1361,0881,532N/A
3/31/20204,6041,3861,2021,618N/A
12/31/20194,4791,3791,1731,598N/A
9/30/20194,2471,3141,0451,384N/A
6/30/20194,0401,2101,0081,307N/A
3/31/20193,8501,1479611,223N/A
12/31/20183,7241,1289821,170N/A
9/30/20183,5708041,0011,164N/A
6/30/20183,457810N/A1,198N/A
3/31/20183,306778N/A1,183N/A
12/31/20173,138671N/A1,144N/A
9/30/20173,003906N/A1,142N/A
6/30/20172,878819N/A1,057N/A
3/31/20172,790780N/A1,102N/A
12/31/20162,707738N/A1,087N/A
9/30/20162,619722N/A1,041N/A
6/30/20162,522678N/A952N/A
3/31/20162,434628N/A875N/A
12/31/20152,367589N/A806N/A
9/30/20152,285546N/A683N/A
6/30/20152,250502N/A654N/A
3/31/20152,179472N/A623N/A
12/31/20142,132419N/A665N/A
9/30/20142,082438N/A700N/A
6/30/20142,031471N/A753N/A
3/31/20142,097526N/A788N/A
12/31/20132,244671N/A880N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 0R29's forecast earnings growth (11.5% per year) is above the savings rate (2.1%).

Earnings vs Market: 0R29's earnings (11.5% per year) are forecast to grow slower than the UK market (14.6% per year).

High Growth Earnings: 0R29's earnings are forecast to grow, but not significantly.

Revenue vs Market: 0R29's revenue (13.4% per year) is forecast to grow faster than the UK market (3.5% per year).

High Growth Revenue: 0R29's revenue (13.4% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 0R29's Return on Equity is forecast to be low in 3 years time (14.3%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y